RxDoctor Payments Data

David Trofa, MD

Orthopaedic Surgery · Eastchester, NYNPI 1003159328

Payments from drug & device makers

What this record shows

This record is dominated by education: $20,875 of the $33,208 with a category attached, or 62.9%. 8 manufacturers reported payments, led by Arthrex at 26.8% of the total. Reporting peaked in 2019 at $15,851 and has fallen 98.2% since, to $282 in 2025.

$33,208in general payments, 2019–2025

Across 108 payments — averaging $307.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$9K
  • Gotham Surgical Solutions & Devices, Inc.$9K
  • Vericel Corporation$6K
  • Peerless Surgical Inc.$5K
  • Smith+Nephew$4K
  • Stryker$591
  • plus $111 from 2 others
$98,423in research payments, 2019–2025

Across 6 payments — averaging $16,404 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$79K
  • Smith+Nephew$19K

What the payments were for

  • Consulting fees$5,50017%
  • Travel & lodging$4,38213%
  • Food & beverage$2,4507%
  • Education$20,87563%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,208 in reported general payments places this provider in the 80th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$57,828
Medicare patients
121
Services billed
1,215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam33$48
Oxycodone Hcl15$40
Ondansetron Hcl12$26

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Eastchester

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →